OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit
http://www.otcpicks.com/microcap.htm today to join this growing community.Our Stocks to Watch tomorrow include Hooper Holmes Inc. (Amex: HH), Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) and General Motors Inc. (NYSE: GM).
Visit
http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.HOOPER HOLMES INCORPORATED (AMEX: HH)
"Up 32.50% on Friday"
Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. As a leading provider of risk assessment services for the insurance industry, Hooper Holmes provides insurers with the widest range of medical exam, data collection, laboratory testing and underwriting services in the industry. With presence in over 250 markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the U.S. and deliver the results to its customers. Each year we arrange millions of medical exams and process 3.8 million specimens in our laboratory. We provide a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission. We underwrite 300,000 cases annually and complete more than two million telephone interviews.
TRUBION PHARMACEUTICALS INCORPORATED (NASDAQ: TRBN)
"Up 37.93% on Friday"
Trubion Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing protein therapeutic product candidates for the treatment of autoimmune and inflammatory diseases, and cancer. Its lead product candidate TRU-015, which has completed a Phase IIb clinical trial is designed for the treatment of rheumatoid arthritis, non-Hodgkin's lymphoma (NHL), and systemic lupus erythematosus. The company also offers TRU-016, a novel CD37-targeted therapy for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia, and NHL. It has collaboration agreement with Wyeth for the development and commercialization of TRU-015 and other therapeutics directed to CD20, an antigen validated clinical target present on B cells; and SMIP product candidates directed to a small number of targets other than CD20. The company was founded in 1999 and is headquartered in Seattle, Washington.
GENERAL MOTORS INCORPORATED (NYSE: GM)
"Up 24.77% on Friday"
General Motors Corporation and its subsidiaries engage in the development, production, and marketing of cars, trucks, and related parts worldwide. It offers small, midsize, sports, and luxury cars; and pickup, van, utilities, and medium duty trucks. The company sells its products under the Chevrolet, Buick, Saab, GMC, Pontiac, Cadillac, HUMMER, Saturn, Opel, Vauxhall, Isuzu, Holden, Daewoo, and Suzuki names. General Motors sells its cars and trucks to dealers for consumer retial sales; and to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. It also offers after sale vehicle services, such as maintenance, light repairs, collision repairs, and vehicle accessories. In addition, the company provides a range of financial services, including consumer vehicle financing, automotive dealership and other commercial financing, residential mortgage services, automobile service contracts, personal automobile insurance coverage, and commercial insurance coverage. General Motors markets its vehicles through a network of independent retail dealers and distributors. As of December 31, 2007, the company operated 6,375 vehicle dealers in the United States, 715 in Canada, and 270 in Mexico, as well as approximately 14,242 distribution outlets internationally. Further, it engages in the development of alternative fuel vehicles. The company was founded in 1908 and is headquartered in Detroit, Michigan.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.